XML 39 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Noncontrolling Interests [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Beginning balance at Dec. 31, 2021 $ 6 $ 5,169   $ 12,004 $ 17 $ (10,072) $ 2   $ 7,126
Beginning balance, common shares at Dec. 31, 2021 630,282,000                
Beginning balance, treasury shares at Dec. 31, 2021           (214,159,000)      
Equity roll forward                  
Consolidated net income       2,238     2   2,240
Other comprehensive income (loss), net of tax         (86)       (86)
Cash dividends declared       (1,077)         (1,077)
Equity-based compensation transactions, net   75   2   $ 73     150
Equity-based compensation transactions, net (in shares)           1,555,000      
Common stock repurchase program   70       $ (1,570)     $ (1,500)
Common stock repurchase program, shares           (9,796,000)     (9,796,000)
Other, net             11   $ 11
Other, net, shares           4,000      
Ending balance at Dec. 31, 2022 $ 6 5,314   13,167 (69) $ (11,569) 15   $ 6,864
Ending balance, common shares at Dec. 31, 2022 630,282,000               407,900,000
Ending balance, treasury shares at Dec. 31, 2022           (222,396,000)      
Equity roll forward                  
Consolidated net income       2,304     (28)   $ 2,276
Other comprehensive income (loss), net of tax         32       32
Cash dividends declared       (1,136)         (1,136)
Equity-based compensation transactions, net   97   (1)   $ 73     169
Equity-based compensation transactions, net (in shares)           1,406,000      
Common stock repurchase program   (60)       $ (1,255)     $ (1,315)
Common stock repurchase program, shares           (7,840,000)     (7,840,000)
Other, net             6   $ 6
Other, net, shares           3,000      
Ending balance at Dec. 31, 2023 $ 6 5,351 $ (12) 14,334 (37) $ (12,751) (7) $ (12) $ 6,896
Ending balance, common shares at Dec. 31, 2023 630,282,000               401,500,000
Ending balance, treasury shares at Dec. 31, 2023           (228,827,000)     (228,827,218)
Equity roll forward                  
Consolidated net income       2,746     (1)   $ 2,745
Other comprehensive income (loss), net of tax         (78)       (78)
Cash dividends declared       (1,210)         (1,210)
Equity-based compensation transactions, net   104       $ 83     187
Equity-based compensation transactions, net (in shares)           1,530,000      
Common stock repurchase program   60       $ (325)     $ (265)
Common stock repurchase program, shares           (1,494,000)     (1,494,000)
Other, net   (19)         10   $ (9)
Other, net, shares           3,000      
Ending balance at Dec. 31, 2024 $ 6 $ 5,496   $ 15,858 $ (115) $ (12,993) $ 2   $ 8,254
Ending balance, common shares at Dec. 31, 2024 630,282,000               401,500,000
Ending balance, treasury shares at Dec. 31, 2024           (228,788,000)     (228,788,284)